SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-017368
Filing Date
2008-03-13
Accepted
2008-03-13 15:39:10
Documents
14
Period of Report
2008-03-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-7877_28k.htm 8-K 38188
2 EX-2.1 a08-7877_2ex2d1.htm EX-2.1 599383
3 EX-10.62 a08-7877_2ex10d62.htm EX-10.62 44933
4 EX-99.1 a08-7877_2ex99d1.htm EX-99.1 21253
5 EX-99.2 a08-7877_2ex99d2.htm EX-99.2 15832
6 GRAPHIC g78772moi001.jpg GRAPHIC 44036
7 GRAPHIC g78772moi002.jpg GRAPHIC 115638
8 GRAPHIC g78772moi003.jpg GRAPHIC 60620
9 GRAPHIC g78772moi004.jpg GRAPHIC 64040
10 GRAPHIC g78772moi005.jpg GRAPHIC 71861
11 GRAPHIC g78772moi006.jpg GRAPHIC 61737
12 GRAPHIC g78772moi007.jpg GRAPHIC 69297
13 GRAPHIC g78772moi008.jpg GRAPHIC 63219
14 GRAPHIC g78772moi009.jpg GRAPHIC 40317
  Complete submission text file 0001104659-08-017368.txt   1536576
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 08686129
SIC: 2834 Pharmaceutical Preparations